The Conversation: You’ve reached your weight loss goal on GLP‑1 medications – what now? Weight loss on GLP-1 drugs can follow similar patterns as the yo-yo dieting fads of previous decades. RapidEye/iStock via Getty Images GLP-1 drugs have ushered in a new era in weight loss.

Understanding the Context

In just a ... You’ve reached your weight loss goal on GLP‑1 medications – what now? Among them is Mounjaro, a once-weekly injectable medication traditionally used for diabetes management that many people now associate with weight loss. Here's what to know about how Mounjaro...

Key Insights

Though Mounjaro is not FDA approved for weight management, some individuals may experience weight loss during Mounjaro treatment. Mounjaro is a brand-name prescription medicine used along... In May 2022, the FDA approved Mounjaro (also known as tirzepatide) for type 2 diabetes management, in addition to diet and exercise. Developed by Eli Lilly, this first-in-class medication has been shown to improve glucose levels and cause weight loss. Morningstar: FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile FDA approves Novo Nordisk's new Wegovy® HD injection, delivering the highest weight loss to date for a Wegovy® injection, adding to its already expansive clinical profile